?? Zhong Medical (688607): Market demand is gradually resuming and the incentive plan is optimistic about subsequent development

Incident: The company released its 2023 annual report: The company achieved operating income of 274 million yuan (+34% year over year) and net profit of 15.41 million yuan (year-on-year reversal of loss to profit). Comment: Market demand is gradually recovering, and new products are steady

光大證券Apr 24 00:00

Kangzhong Medical (688607): New product release+demand recovery, domestic market growth of 48%

Incident: The company released its 2023 annual report, achieved operating income of 274 million yuan (yoy +34%) in 2023, achieved net profit of 15.41 million yuan, deducted net profit not returned to mother of 970,000 yuan, generated from operating activities

信達證券Apr 22 00:00

Kangzhong Healthcare (688607.SH): Plans to launch a 780,000 restricted stock incentive plan

Gelonghui, April 19 | Kangzhong Healthcare (688607.SH) announced the 2024 restricted stock incentive plan. This incentive plan grants a total of 7800 million restricted shares, accounting for 0.89% of the company's total share capital when this incentive plan was announced. Among them, 75,000 shares were granted for the first time, accounting for 0.85% of the company's total share capital when the incentive plan was announced, accounting for 96.15% of the total amount of restricted shares granted under the incentive plan; 30 million shares were reserved, accounting for 0.03% of the company's total share capital when the incentive plan was announced, and 3.85% of the total restricted stock granted under the incentive plan.

Gelonghui FinanceApr 19 20:29

Kangzhong Healthcare (688607.SH): Net profit of 154.12,200 yuan in 2023 turned a year-on-year loss into a profit

Gelonghui, April 19 | Kangzhong Healthcare (688607.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 274 million yuan, an increase of 33.81% over the previous year; net profit to mother was 154.12,200 yuan, turning a year-on-year loss into a profit; deducting 968,200 yuan in non-net profit; and basic earnings per share of 0.17 yuan. The company plans to distribute a cash dividend of RMB 0.54 (tax included) for every 10 shares to all shareholders.

Gelonghui FinanceApr 19 20:28

CareRay Digital Medical Technology Buys Back 10 Million Yuan Worth of Shares; Shares Up 9%

CareRay Digital Medical Technology (SHA:688607) repurchased shares for nearly 10 million yuan, according to the company's dislcosure on the Shanghai Stock Exchange. The Chinese digital radiography ser

MT NewswiresApr 17 15:03

Kangzhong Medical (688607.SH): cumulative repurchase of 0.8371% of shares

Gelonghui, April 16, 丨 Kangzhong Medical (688607.SH) announced that as of April 15, 2024, the company had repurchased a total of 737,722 shares of the company through centralized bidding transactions, accounting for 0.8371% of the company's total share capital. The highest price of the repurchase transaction was 14.49 yuan/share, the lowest price was 12.64 yuan/share, and the total capital paid was RMB 9,997,724.29 (excluding transaction fees such as stamp duty and transaction fees).

Gelonghui FinanceApr 16 19:03